fda bpc 157 compounding category 2 list Peptide Regulations 2026: What Patients Need to Know FDA Adds Several Peptides to
Description
This is a meaningful risk that exists entirely separately from any pharmacologic risk the compound itself may or may not carry
Legality depends on the compound and its intended use
The treatment may support health benefits, including improved liver function, enhanced metabolism, and potential support for cardiovascular health [6]
S2CID 4978703
